Avenin diversity analysis of the genus Avena (oat): Relevance for people with celiac disease

Journal of Cereal Science

Volumn 58, Issue 1, 2013, Pages 170-177

  Londono, D M ^a   van't Westende, W P C ^a   Goryunova, S ^b   Salentijn, E M J ^a   van den Broeck, H C ^a   van der Meer, I M ^a   Visser, R G F ^a   Gilissen, L J W J ^a   Smulders, M J M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

Author keywords

Celiac disease; G12 antibody; Gluten free; R5 antibody

Indexed keywords

AVENA; HORDEUM; SECALE CEREALE; TRITICUM AESTIVUM;

EID: 84880044805     PISSN: 07335210     EISSN: 10959963     Source Type: Journal    
DOI: 10.1016/j.jcs.2013.03.017     Document Type: Article

References (30)

1. Anderson R.P., Degano P., Godkin A.J., Jewell D.P., Hill A.V.S. Invivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nature Medicine 2000, 6:337-342.
2. Andon M., Anderson J. The oatmeal-cholesterol connection: 10 years later. American Journal of Lifestyle Medicine 2008, 2:51-57.
3. Arentz-Hansen H., Fleckenstein B., Molberg O., Scott H., Koning F., Jung G., Roepstorff P., Lundin K.E.A., Sollid L.M. The molecular basis for oat intolerance in patients with Celiac disease. Plos Medicine 2004, 1:84-92.
4. Chesnut R.S., Shotwell M.A., Boyer S.K., Larkins B.A. Analysis of avenin proteins and the expression of their messenger-RNAs in developing oat seeds. Plant Cell 1989, 1:913-924.
5. Comino I., Real A., de Lorenzo L., Cornell H., López-Casado M.Á., Barro F., Lorite P., Torres M.I., Cebolla Á., Sousa C. Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease. Gut 2011, 60:915-922.
6. Gelinas P., McKinnon C.M., Mena M.C., Mendez E. Gluten contamination of cereal foods in Canada. International Journal of Food Science and Technology 2008, 43:1245-1252.
7. Janatuinen E.K., Pikkarainen P.H., Kemppainen T.A., Kosma V.M., Jarvinen R.M.K., Uusitupa M.I.J., Julkunen R.J.K. Acomparison of diets with and without oats in adults with celiac disease. New England Journal of Medicine 1995, 333:1033-1037.
8. Koskinen O., Villanen M., Korponay-Szabo I., Lindfors K., Maki M., Kaukinen K. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease. Journal of Pediatric Gastroenterology and Nutrition 2009, 48:559-565.
9. Loskutov I.G. On evolutionary pathways of Avena species. Genetic Resources and Crop Evolution 2008, 55:211-220.
10. Lundin K.E.A., Nilsen E.M., Scott H.G., Loberg E.M., Gjoen A., Bratlie J., Skar V., Mendez E., Lovik A., Kett K. Oats induced villous atrophy in coeliac disease. Gut 2003, 52:1649-1652.
11. Mitea C., Salentijn E.M.J., van Veelen P., Goryunova S.V., van der Meer I.M., van den Broeck H.C., Mujico J.R., Montserrat V., Gilissen L.J.W.J., Drijfhout J.W., Dekking L., Koning F., Smulders M.J.M. Auniversal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease. Plos One 2010, 5:e15637.
12. Moron B., Cebolla A., Manyani H., Alvarez-Maqueda M., Megias M., Thomas M.D.C., Lopez M.C., Sousa C. Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide. American Journal of Clinical Nutrition 2008, 87:405-414.
13. Mujico J.R., Mitea C., Gilissen L.J.W.J., de Ru A., van Veelen P., Smulders M.J.M., Koning F. Natural variation in avenin epitopes among oat varieties: implications for Celiac disease. Journal of Cereal Science 2011, 54:8-12.
14. Osman A.A., Uhlig H.H., Valdes I., Amin M., Mendez E., Mothes T. Amonoclonal antibody that recognizes a potential toxic repetitive pentapeptide epitope in gliadins. European Journal of Gastroenterology & Hepatology 2001, 13:1189-1193.
15. Pernollet J.-C., Huet J.-C., Galle A.-M., Sallantin M. N-terminal sequences of oat avenins compared to other cereal prolamins. Biochimie 1987, 69:683-689.
16. Pulido O., Gillespie Z., Zarkadas M., Dubois S., Vavasour E., Rashid M., Switzer C., Godefroy B.S. Introduction of oats in the diet of individuals with celiacdisease: a systematic review. Advances in Food and Nutrition Research 2009, 57:235-285.
17. Salentijn E.M.J., Mitea D.C., Goryunova S.V., Van der Meer I.M., Padioleau I., Gillissen L.J.W.J., Koning F., Smulders M.J.M. Celiac disease T cell epitopes from gamma-gliadins: immunoreactivity depends on the genome oforigin, transcript frequency, and flanking protein variation. BMC Genomics 2012, 13:277.
18. Salovaara H.O., Kanerva P., Loponen J., Sontag-Strohm T.S. Oats in gluten-free diet, considerations of a pragmatic policy. Second International Symposium on Gluten-free Cereal Products and Beverages 2010, 193-194. University of Helsinki, Tampere, Finland.
19. Shewry P.R., Tatham A.S., Barro F., Barcelo P., Lazzeri P. Biotechnology of breadmaking: unraveling and manipulating the multi-protein gluten complex. Biotechnology 1995, 13:1185-1190.
20. Silano M., Di Benedetto R., Maialetti F., De Vincenzi A., Calcaterra R., Cornell H.J., De Vincenzi M. Avenins from different cultivars of oats elicit response by coeliac peripheral lymphocytes. Scandinavian Journal of Gastroenterology 2007, 42:1302-1305.
21. Sollid L.M., Qiao S.W., Anderson R.P., Gianfrani C., Koning F. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics 2012, 64:455-460.
22. Spaenij-Dekking L., Kooy-Winkelaar Y., Van Veelen P., Drijfhout J.W., Jonker H., Van Soest L., Smulders M.J.M., Bosch D., Gilissen L., Koning F. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 2005, 129:797-806.
23. Tatham A.S., Gilbert S.M., Fido R.J., Shewry P.R. Extraction, separation and purification of wheat gluten proteins and related proteins of barley, rye and oats. Methods in Molecular Medicine 2000, 41:55-73.
24. Thompson T. Oats and the gluten-free diet. Journal of the American Dietetic Association 2003, 103:376-379.
25. Tuire I., Marja-leena L., Teea S., Katri H., Jukka P., Päivi S., Heini H., Markku M., Pekka C., Katri K. Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease. The American Journal of Gastroenterology 2012, 107:1563-1569.
26. Vader L.W., Stepniak D.T., Bunnik E.M., Kooy Y.M.C., De Haan W., Drijfhout J.W., Van Veelen P.A., Koning F. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 2003, 125:1105-1113.
27. Valdes I., Garcia E., Llorente M., Mendez E. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol. European Journal of Gastroenterology & Hepatology 2003, 15:465-474.
28. van den Broeck H.C., Gilissen L.J.W.J., Smulders M.J.M., van der Meer I.M., Hamer R.J. Dough quality of bread wheat lacking alpha-gliadins with celiac disease epitopes and addition of celiac-safe avenins to improve dough quality. Journal of Cereal Science 2011, 53:206-216.
29. van Herpen T., Goryunova S.V., van der Schoot J., Mitreva M., Salentijn E., Vorst O., Schenk M.F., van Veelen P.A., Koning F., van Soest L.J.M., Vosman B., Bosch D., Hamer R.J., Gilissen L.J.W.J., Smulders M.J.M. Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes. BMC Genomics 2006, 7:1.
30. Zevallos V.F., Ellis H.J., Šuligoj T., Herencia L.I., Ciclitira P.J. Variable activation of immune response by quinoa (Chenopodium quinoa Willd.) prolamins in celiac disease. The American Journal of Clinical Nutrition 2012, 96:337-344.